24/7 Market News Snapshot 23 October, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)

October 23, 2025

DENVER, Colo., 23 October, 2025 (www.247marketnews.com) – (NASDAQ:INBS) are discussed in this article.
Intelligent Bio Solutions Inc. (INBS) is currently experiencing a bullish trend in pre-market trading, with shares priced at $1.055, marking a significant increase of 6.59% from the previous close of $0.990. The strong trading volume of 2.92 million shares reflects heightened investor interest, indicative of positive sentiment surrounding the stock. This upward momentum may stem from favorable market conditions or pivotal company developments, prompting traders to keep an eye on key resistance levels and overarching market trends. Sustained upward movement could attract more buyers, while potential dips might offer attractive entry points, positioning INBS for potential short-term gains.

Concurrently, Intelligent Bio Solutions has secured a landmark contract with a major multinational industrial service provider, underscoring its leading role in medical technology through innovative, rapid, non-invasive testing solutions. This partnership is a key milestone in the company’s mission to enhance workforce safety and streamline compliance processes across high-volume, safety-sensitive sectors, including energy, defense, and industrial services.

The agreement signifies growing confidence in Intelligent Bio Solutions’ proprietary drug testing technology, notably the Intelligent Fingerprinting Drug Screening System. This system presents a transformative alternative to conventional urine-based tests known for their slow and disruptive nature. The client expects that adopting this technology will streamline their testing process, significantly reducing operational downtime and boosting productivity.

Harry Simeonidis, President and CEO, remarked, “Securing this account highlights the expanding market confidence in our technology and its growing role in transforming drug testing across some of the world’s largest industrial operators.” With the system currently utilized in over 480 accounts across 24 countries, its swift results—typically under ten minutes—position it as an appealing solution for various industries, reinforcing Intelligent Bio Solutions’ commercial trajectory and recurring revenue potential.

Related news for (INBS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.